Side Effects to Expect When You Increase Your Ozempic Dose

Nausea and vomiting rise most after an Ozempic step-up, affecting 20.3% and 9.2% of people on 1 mg in the label’s trials, against 15.8% and 5% on 0.5 mg (Ozempic prescribing information, section 6.1). In trials of semaglutide 2.4 mg, a nausea episode lasted a median of 8 days (Wharton et al., 2022).

Key facts

• Each Ozempic dose peaks in the blood 1 to 3 days after the shot (Ozempic label, section 12.3).
• The next step is only for blood sugar that needs more control, except with chronic kidney disease, where the higher dose is the maintenance dose (Ozempic label, section 2.2).
• In a 30-week trial of Ozempic alone, weight fell 4.7 kg on the higher dose and 3.8 kg on the lower, against 1.2 kg with placebo (Ozempic label, section 14).
• The STEP 1 to 3 trials saw nausea, diarrhea and vomiting peak around week 20, four weeks after the final step (Wharton et al., 2022).
• Call about severe stomach pain, gallbladder signs, low blood sugar, vision changes, or vomiting or diarrhea that will not stop (Ozempic Medication Guide).

Ozempic side effects by dose

The label’s figures for Ozempic 0.5 mg and 1 mg pool two placebo-controlled trials in adults with type 2 diabetes, about 260 people a group. On placebo, 6.1% had nausea and 15.3% had any stomach side effect (Ozempic label, sections 5.7 and 6.1).

Each column is a different group of people, assigned to one dose from the start. The figures show how common a symptom was on each dose, not your own chance of it in the week after a step-up. Diarrhea barely changed between the doses, and abdominal pain and constipation were reported less often on 1 mg.

The label notes that the majority of nausea, vomiting and diarrhea reports came while the dose was being raised. Going higher again, a 40-week trial of 959 people compared 2 mg with 1 mg, and stomach side effects affected 34% against 30.8% (Ozempic label, section 6.1).

How long side effects last after a dose increase

The Ozempic label gives no durations. The nearest published figures come from STEP 1, 2 and 3, trials of semaglutide 2.4 mg in adults with overweight or obesity, where the dose went up every 4 weeks (Wharton et al., 2022).

In those trials, among people who had any stomach side effect, "the vast majority experienced their first event during the dose-escalation period". Nausea, diarrhea and vomiting episodes lasted about as long on placebo as on semaglutide; constipation on placebo lasted a median of 35 days.

We found no published trial that reports which day after a shot stomach symptoms are worst, so the timing of side effects after a weekly shot is read from the drug’s level. To see where each weekly peak falls for your own doses, Pensday draws a level curve from the shots you log.

What the higher dose does for blood sugar and weight

In the label’s 30-week trial of Ozempic on its own, weight fell 3.8 kg on 0.5 mg and 4.7 kg on 1 mg, against 1.2 kg on placebo (Ozempic label, section 14.1, Table 3). HbA1c fell by 1.4 and 1.6 percentage points on the two doses, and by 0.1 on placebo.

A step to 2 mg gave less extra. In a 40-week trial against 1 mg, HbA1c fell by 2.1 points on 2 mg and 1.9 on 1 mg (Ozempic label, section 14.1, Table 7). Weight fell 6.4 kg against 5.6 kg, a difference the label calls "not statistically significant".

When you can step up

Ozempic starts at 0.25 mg for 4 weeks and then moves to 0.5 mg. After at least 4 weeks on 0.5 mg, 1 mg is allowed "if additional glycemic control is needed" (Ozempic label, section 2.2). The same condition applies to 2 mg, after at least 4 weeks on 1 mg. With type 2 diabetes and chronic kidney disease, 1 mg is the maintenance dose.

The dose titration planner gives the earliest date for your next Ozempic step from the day your current dose began. For a compounded vial, the semaglutide dose calculator converts the new dose into syringe units. The same drug climbs further as Wegovy, and every GLP‑1 brand’s dose ladder sits on one chart.

In the UK, the Summary of Product Characteristics (SmPC) uses the same steps and calls 0.25 mg "not a maintenance dose" (Ozempic SmPC, section 4.2). Each increase above 0.5 mg is there "to further improve glycaemic control". Ozempic tablets climb on their own ladder: 1.5 mg for 30 days, then 4 mg, then 9 mg from day 61 if needed (Rybelsus and Ozempic tablets label, section 2.2).

If a new dose is hard to tolerate

Neither Ozempic label covers delaying a step or going back down. At weight-loss doses of the same drug, the US Wegovy label suggests waiting 4 more weeks before the next increase if a dose is poorly tolerated (Wegovy prescribing information, section 2.2).

A Spanish multidisciplinary consensus gives clinicians options for stomach side effects that start during escalation (Gorgojo-Martínez et al., 2022). They are 2 to 4 more weeks on the previous dose or a pause, no increase while symptoms last, or a few days back on the lower dose before stepping up again.

A 2025 advisory by four US obesity and nutrition groups notes that in clinical trials, people could stay on a GLP‑1 dose "for up to 8 weeks, as needed" (Mozaffarian et al., 2025). In STEP 1 to 3, stomach side effects led to a lower dose or a pause for 12.5% of people on semaglutide 2.4 mg, against 1.7% on placebo (Wharton et al., 2022).

Eating and drinking after a step-up

Nausea "often occurs in the morning or after longer periods without eating", according to the Mozaffarian advisory (Mozaffarian et al., 2025). When nausea puts you off food, which can make it worse, the advisory says people can be counseled to eat breakfast "and then small meals every 3–4 h while drinking adequate fluids". Vomiting is more likely after large meals, it adds.

The Ozempic Medication Guide warns that diarrhea, nausea and vomiting can cause a loss of fluids that may lead to kidney problems, and says "it is important for you to drink fluids" (Ozempic Medication Guide). For a daily fluid figure to aim at, use the water intake calculator.

Symptoms that need a call

The Ozempic Medication Guide and label give these reasons to contact your healthcare provider (Ozempic prescribing information, sections 5 and 17, and Medication Guide):

• Severe pain in your stomach area that will not go away, with or without vomiting, sometimes felt through to your back. This can mean pancreatitis: "Stop using OZEMPIC and call your healthcare provider right away."
• Pain in your upper stomach, yellowing of your skin or eyes, fever or clay-colored stools, which can be gallbladder problems.
• Nausea, vomiting or diarrhea that does not go away, because the fluid loss can harm your kidneys.
• Stomach problems that are severe or will not go away.
• Signs of low blood sugar, such as shakiness, sweating, confusion, dizziness or a fast heartbeat, especially if you also take a sulfonylurea or insulin.
• Changes in your vision. A fast improvement in blood sugar has been linked to a temporary worsening of diabetic eye disease (Ozempic label, section 5.3).